CNTG News and Press, Centogene N.V. From 02/08/22

Centogene (NASDAQ:CNTG) plans for the transition of CFO René Just and the appointment of Miguel Coego Rios as EVP, Finance & Legal and Interim CFO. René Just has resigned effective Mar.31, 2022 post filing of the company's annual report; Miguel Coeg...

CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, Feb. 08, 2022 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on generating data-driven insights to diagnose, understand, and treat rare diseases, today announced plans for the transition of Chief Finan...

Centogene N.V. (NASDAQ:CNTG) has appointed Kim Stratton as Chief Executive Officer, transitioning from her prior designation as Interim CEO. This nomination follows extension of medical leave by Dr. Andrin Oswald, the company’s Chief Executive Officer and Managing Director, who ha...

CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, Feb. 01, 2022 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on generating data-driven insights to diagnose, understand, and treat rare diseases, today announced the nomination of Prof. Andreas Busch a...

Enables refocusing on core business of delivering valuable, data-driven insights to patients, and pharmaceutical companies globally EUR 15 million private placement from leading growth investors and a USD 45 million senior secured loan from Oxford Finance to fortify CENTOGENE&...

CAMBRIDGE, Mass. and ROSTOCK, Germany, and BERLIN, Feb. 01, 2022 (GLOBE NEWSWIRE) -- Centogene N.V. (Nasdaq: CNTG), a commercial-stage company focused on generating data-driven insights to diagnose, understand, and treat rare diseases, today announced the Company’s Supervisory Board&...

CENTOGENE and Insilico Medicine will work together to identify, rank, and annotate proteins to identify novel therapeutic targets for NPC using AI NPC is a rare genetic disease occurring in approximately 1 in 120,000 live births, with many cases going mis- or undiagnosed There are...

Arcensus has appointed Prof. Dr. Arndt Rolfs as New CEO Hoboken, NJ, Rostock & Berlin, Germany, Jan 12, 2022 - (ACN Newswire) - Arcensus, a commercial-stage digital healthcare and diagnostics company that empowers people to take control of their health is pleased to announ...

The CentoCloud solution is a cloud-based Software as a Service (SaaS) platform that enables laboratories around the world to analyze, interpret, and report genomic variants, and will be able to utilize the power of proprietary reagent kits CENTOGENE is developing in collaboration with Twi...

Gainers: Insignia Systems (NASDAQ:ISIG) +83%.. Pop Culture (NASDAQ:CPOP) +24%. Regencell Bioscience RGC +20% BridgeBio Pharma BBIO +19%. Gamida Cell (NASDAQ:GMDA) +17%. ADDvantage Technologies (NASDAQ:AEY) +17%. Centogene (NASDAQ:CNTG) +14% Altamira Therapeu...